Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adrenocortical Hyperfunction × pembrolizumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 76 Lung Neoplasms 33 Parkinson Disease 4, Autosomal Dominant Lewy Body 32 Melanoma 32 Squamous Cell Carcinoma of Head and Neck 27 Neoplasms 22 Triple Negative Breast Neoplasms 21 Colorectal Neoplasms 20 Breast Neoplasms 20 Neoplasm Metastasis 18 Ovarian Neoplasms 16 Carcinoma, Transitional Cell 15 Endometrial Neoplasms 14 Stomach Neoplasms 13 Carcinoma, Renal Cell 12 Carcinoma 12 Urinary Bladder Neoplasms 11 Esophageal Neoplasms 11 Uterine Cervical Neoplasms 10 Pancreatic Neoplasms 10 Recurrence 7 Esophageal Squamous Cell Carcinoma 7 Head and Neck Neoplasms 6 Small Cell Lung Carcinoma 5 Mouth Neoplasms 5 Lymphoma 5 Laryngeal Neoplasms 5 Glioblastoma 5 Colonic Neoplasms 5 Cholangiocarcinoma 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡